Zheng Tan
Chairman at IMMUNOTECH BIOPHARM LTD
Net worth: 88 M $ as of 30/03/2024
Profile
Zheng Tan is currently the Chairman at Immunotech Biopharm Ltd., Ankang Ruihe Biomedical Technology (Beijing) Co., Ltd., Brainaurora Medical Technology Ltd., and Director at Jy Research Holdings Ltd.
He previously worked as the Deputy General Manager at Wuhan Heer Medical Technology Development Co. Ltd.
and Supervisor-Beijing Officer at Shaanxi Kanghui Pharmaceutical Co., Ltd.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
IMMUNOTECH BIOPHARM LTD
36.04% | 19/02/2023 | 185,480,000 ( 36.04% ) | 88 M $ | 30/03/2024 |
Zheng Tan active positions
Companies | Position | Start |
---|---|---|
IMMUNOTECH BIOPHARM LTD | Chairman | 31/07/2019 |
Jy Research Holdings Ltd. | Director/Board Member | - |
Immunotech Applied Science Ltd. | Director/Board Member | 31/08/2015 |
Ankang Ruihe Biomedical Technology (Beijing) Co., Ltd.
Ankang Ruihe Biomedical Technology (Beijing) Co., Ltd. Information Technology ServicesTechnology Services Ankang Ruihe Biomedical Technology (Beijing) Co., Ltd. was founded in 2008 and provides technical development and consulting services. The company is based in Beijing, China and has subsidiaries in China. | Chairman | - |
Brainaurora Medical Technology Ltd.
Brainaurora Medical Technology Ltd. BiotechnologyHealth Technology Brainaurora Medical Technology Ltd. engages in research and development of medical-grade cognitive impairment digital therapeutics (DTx) products. It offers the advanced artificial intelligence technologies and products for the treatment of cognitive impairment diseases. The company was founded on April 25, 2023 and is headquartered in Shaoxing, China. | Chairman | 24/04/2023 |
Former positions of Zheng Tan
Companies | Position | End |
---|---|---|
Wuhan Heer Medical Technology Development Co. Ltd.
Wuhan Heer Medical Technology Development Co. Ltd. Medical SpecialtiesHealth Technology Part of Boai NKY Medical Holdings Ltd., Wuhan Heer Medical Technology Development Co. Ltd. engages in medical equipment development operation. The private company is based in Wuhan, China. Wuhan Heer Medical Technology Development Co. was acquired by Boai NKY Medical Holdings Ltd. on November 13, 2014 for $46.72 million. | Corporate Officer/Principal | 31/07/2015 |
SHAANXI KANGHUI PHARMACEUTICAL CO., LTD. | Corporate Officer/Principal | 31/12/2012 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
SHAANXI KANGHUI PHARMACEUTICAL CO., LTD. | Health Technology |
IMMUNOTECH BIOPHARM LTD | Health Technology |
Private companies | 5 |
---|---|
Jy Research Holdings Ltd. | |
Immunotech Applied Science Ltd. | |
Ankang Ruihe Biomedical Technology (Beijing) Co., Ltd.
Ankang Ruihe Biomedical Technology (Beijing) Co., Ltd. Information Technology ServicesTechnology Services Ankang Ruihe Biomedical Technology (Beijing) Co., Ltd. was founded in 2008 and provides technical development and consulting services. The company is based in Beijing, China and has subsidiaries in China. | Technology Services |
Brainaurora Medical Technology Ltd.
Brainaurora Medical Technology Ltd. BiotechnologyHealth Technology Brainaurora Medical Technology Ltd. engages in research and development of medical-grade cognitive impairment digital therapeutics (DTx) products. It offers the advanced artificial intelligence technologies and products for the treatment of cognitive impairment diseases. The company was founded on April 25, 2023 and is headquartered in Shaoxing, China. | Health Technology |
Wuhan Heer Medical Technology Development Co. Ltd.
Wuhan Heer Medical Technology Development Co. Ltd. Medical SpecialtiesHealth Technology Part of Boai NKY Medical Holdings Ltd., Wuhan Heer Medical Technology Development Co. Ltd. engages in medical equipment development operation. The private company is based in Wuhan, China. Wuhan Heer Medical Technology Development Co. was acquired by Boai NKY Medical Holdings Ltd. on November 13, 2014 for $46.72 million. | Health Technology |
- Stock Market
- Insiders
- Zheng Tan